In silico Screening of Chemical Libraries to Develop Inhibitors That Hamper the Interaction of PCSK9 with the LDL Receptor

PURPOSE: Proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low density lipoprotein receptor (LDLR) and promotes degradation of the LDLR. Inhibition of PCSK9 either by reducing its expression or by blocking its activity results in the upregulation of the LDLR and subsequently lowers...

Descripción completa

Detalles Bibliográficos
Autores principales: Min, Dong-Kook, Lee, Hyun-Sook, Lee, Narae, Lee, Chan Joo, Song, Hyun Joo, Yang, Ga Eul, Yoon, Dojun, Park, Sahng Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541654/
https://www.ncbi.nlm.nih.gov/pubmed/26256967
http://dx.doi.org/10.3349/ymj.2015.56.5.1251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541654/
https://www.ncbi.nlm.nih.gov/pubmed/26256967
http://dx.doi.org/10.3349/ymj.2015.56.5.1251

Ejemplares similares